- Home
- NTRP vs DRMA Comparison
NTRP vs DRMA Comparison
Compare NTRP & DRMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTRP
- DRMA
- Stock Information
- Founded
- NTRP 1985
- DRMA 2014
- Country
- NTRP United States
- DRMA United States
- Employees
- NTRP N/A
- DRMA N/A
- Industry
- NTRP
- DRMA Biotechnology: Pharmaceutical Preparations
- Sector
- NTRP
- DRMA Health Care
- Exchange
- NTRP NYSE
- DRMA Nasdaq
- Market Cap
- NTRP 6.7M
- DRMA 6.1M
- IPO Year
- NTRP N/A
- DRMA 2021
- Fundamental
- Price
- NTRP $5.32
- DRMA $0.93
- Analyst Decision
- NTRP Hold
- DRMA Strong Buy
- Analyst Count
- NTRP 1
- DRMA 1
- Target Price
- NTRP $5.00
- DRMA $6.00
- AVG Volume (30 Days)
- NTRP 45.3K
- DRMA 4.1M
- Earning Date
- NTRP 04-15-2025
- DRMA 05-14-2025
- Dividend Yield
- NTRP N/A
- DRMA N/A
- EPS Growth
- NTRP N/A
- DRMA N/A
- EPS
- NTRP N/A
- DRMA N/A
- Revenue
- NTRP $623,664.00
- DRMA N/A
- Revenue This Year
- NTRP $354.28
- DRMA N/A
- Revenue Next Year
- NTRP $536.37
- DRMA N/A
- P/E Ratio
- NTRP N/A
- DRMA N/A
- Revenue Growth
- NTRP 186.93
- DRMA N/A
- 52 Week Low
- NTRP $1.39
- DRMA $0.90
- 52 Week High
- NTRP $8.50
- DRMA $6.66
- Technical
- Relative Strength Index (RSI)
- NTRP 53.73
- DRMA 33.18
- Support Level
- NTRP $5.01
- DRMA $1.16
- Resistance Level
- NTRP $6.48
- DRMA $2.37
- Average True Range (ATR)
- NTRP 0.69
- DRMA 0.17
- MACD
- NTRP 0.11
- DRMA -0.04
- Stochastic Oscillator
- NTRP 54.55
- DRMA 2.19
About NTRP NEXTTRIP INC
NextTrip Inc is a technology-driven platform delivering travel booking and travel media solutions. It provides individual and group travelers with vacations to popular and sought-after destinations in Mexico, the Caribbean, and across the world. NextTrip Media platform - Travel Magazine offers a social media platform for viewers to explore, educate, and share with friends their bucket list travel. The company is also launching an end-to-end content ecosystem that uses AI-assisted travel planning capturing advertising, building brand awareness, rewarding loyalty, and driving bookings.
About DRMA Dermata Therapeutics Inc.
Dermata Therapeutics Inc is a clinical-stage medical dermatology company focused on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions and diseases. Its two product candidates, DMT310 and DMT410, incorporate its proprietary, multifaceted, Spongilla technology to topically treat a variety of dermatological conditions. Its Spongilla technology platform will enable to develop and formulate singular and combination products that are able to target topical delivery of chemical compounds into the dermis for maximum treatment effect for a variety of inflammatory skin diseases.